We are your lentivirus specialized partner. Come meet us!

VIVEbiotech is a Contract Development and Manufacturing Organization -CDMO- developing and GMP manufacturing lentiviral vectors with wide and robust experience in manufacturing vectors for rare/ultrarare diseases and for immune-cell therapy projects i.e. CAR-Ts, TCRs... 
VIVEbiotech operates according to both the FDA´s and the EMA´s standards, and is manufacturing vectors for companies based in the US, Europe, Asia and Australia. VIVEbiotech can manufacture lentiviral vectors from scratch up to commercial-scale, both for ex-vivo and in-vivo use.


 Products

  • Lentiviral vector development and manufacturing
    VIVEbiotech is a CDMO developing and manufacturing lentiviral vectors with wide experience in manufacturing vectors for rare diseases and for immune-cell therapy projects

    ...

  • VIVEbiotech offers a wide range of manufacturing-related services on the lentiviral vectors produced, such as:

    • Early-phase development adapted to the requirements of each vector:
      • Cloning activities: from design to cloning aimed at increasing productivity and conforming to regulatory requirements, among others.
      • Various ad-hoc optimization activities: from adaptations in producer cell lines, to adjustments in transfection, to different pseudotyping strategies, etc.
      • R&D manufacture in 2D format.
    • R&D manufacture in bioreactors.
    • Manufacture of engineering batches for preclinical phases.
    • GMP batches for clinical and commercial phases.
    • Batch release by our own Qualified Person.
    • Stability studies: long-term and in-use.
    • Regulatory support including:
      • Chemistry, Manufacturing and Control (CMC) section of the Investigational Medicinal Product Dossier (IMPD).
      • Chemistry, Manufacturing and Control (CMC) section of Investigational New Drug (IND).
    • Comprehensive management of outsourced partners (analytical testing and plasmid manufacturing, among others).